Heart Failure – an Evolving Landscape: Evidence-based approaches to the management of HFpEF 

Published: 07 October 2021

  • Views:

    Views Icon 375
  • Likes:

    Heart Icon 7

Overview

Full programme

  • Views:

    Views Icon 375
  • Likes:

    Heart Icon 7
Part 4

of 4

Application of using SGLT-2 inhibitors in HFpEF

Andrew JS Coats, Shelley Zieroth, Javed Butler, Stefan Anker

Overview

In this second roundtable of the series, we consider the recent dramatic advances to the management of HFpEF. 

 

Prof Andrew Coats is joined by Dr Shelley Zieroth, Dr Javed Butler and Prof Stefan Anker for their assessment of the current treatment landscape following the publication of EMPEROR-PRESERVED. During this roundtable they discuss current unmet needs in HFpEF, the recent advances in HFpEF treatment, the importance of EF in relation to treatment selection and, in the final session, consider how to best implement empaglifozin in the real world.

 

 

Supported by the Boehringer Ingelheim & Lilly Alliance

More from this programme

Faculty biographies